Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 26.40
0.00 (0.00%)
Jun 26, 2026, 4:59 PM CET
Embla Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 85.63 | 83.34 | 68.28 | 58.39 | 42.51 | 63.99 |
Depreciation & Amortization | 54.84 | 54.72 | 49.4 | 43.33 | 43.49 | 45.54 |
Other Amortization | 7.39 | 5.9 | 6.58 | 6.59 | 5.87 | 5.99 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.12 |
Other Operating Activities | -8.15 | -5.61 | 2.37 | -2.88 | -11.82 | 6.5 |
Change in Accounts Receivable | -10.1 | -12.32 | -5.52 | -16.37 | -13.2 | -13.18 |
Change in Inventory | -2.47 | -8.59 | -5.93 | -2.27 | -28.62 | -15.78 |
Change in Accounts Payable | -1.63 | 11.33 | -2.28 | 14.9 | 10.94 | 7.76 |
Change in Other Net Operating Assets | 2.55 | 3.86 | 3.17 | -7.37 | 11.58 | -0.4 |
Operating Cash Flow | 128.06 | 132.62 | 116.07 | 94.32 | 60.77 | 100.53 |
Operating Cash Flow Growth | 1.77% | 14.26% | 23.05% | 55.21% | -39.55% | 8.99% |
Capital Expenditures | -19.96 | -22.07 | -27.03 | -29.23 | -16.55 | -16.96 |
Cash Acquisitions | -14.97 | -14.69 | -70.07 | -11.9 | -41.78 | -33.94 |
Sale (Purchase) of Intangibles | -11.58 | -10.26 | -12.19 | -13.05 | -9.4 | -9.73 |
Other Investing Activities | -15.42 | 0.9 | 4.53 | -2.97 | 1.47 | 1.18 |
Investing Cash Flow | -61.93 | -46.13 | -104.77 | -57.15 | -66.26 | -59.45 |
Long-Term Debt Issued | - | 57.46 | 39.79 | - | 101.42 | 1.69 |
Long-Term Debt Repaid | - | -117.33 | -24.38 | -40.2 | -87.06 | -51.44 |
Net Debt Issued (Repaid) | -50.01 | -59.87 | 15.41 | -40.2 | 14.36 | -49.74 |
Repurchase of Common Stock | -11.09 | -9.75 | - | - | -9.94 | - |
Other Financing Activities | -5.16 | -5.16 | -9.65 | -0.76 | -0.63 | -1.33 |
Financing Cash Flow | -66.26 | -74.78 | 5.76 | -40.96 | 3.79 | -51.07 |
Foreign Exchange Rate Adjustments | 2.02 | 4.63 | -3.55 | -0.2 | -6.86 | -7.18 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | - | -0 | - |
Net Cash Flow | 1.89 | 16.34 | 13.51 | -3.98 | -8.57 | -17.17 |
Free Cash Flow | 108.1 | 110.55 | 89.03 | 65.09 | 44.22 | 83.57 |
Free Cash Flow Growth | 3.83% | 24.16% | 36.78% | 47.19% | -47.08% | 6.50% |
Free Cash Flow Margin | 11.28% | 11.90% | 10.42% | 8.29% | 6.15% | 11.63% |
Free Cash Flow Per Share | 0.26 | 0.26 | 0.21 | 0.15 | 0.11 | 0.20 |
Cash Interest Paid | 20.19 | 20.55 | 24.08 | 16.05 | 13.11 | 12.15 |
Cash Income Tax Paid | 27.82 | 26.6 | 23.49 | 20.35 | 19.66 | 16.3 |
Levered Free Cash Flow | 73.67 | 108.47 | 69.47 | 24.48 | 52.4 | 79.11 |
Unlevered Free Cash Flow | 85.63 | 120.67 | 84 | 35.7 | 59.4 | 85.23 |
Change in Working Capital | -11.65 | -5.73 | -10.56 | -11.11 | -19.29 | -21.61 |